ID   CILK1_HUMAN             Reviewed;         632 AA.
AC   Q9UPZ9; A7MD41; O75985; Q5THL2; Q8IYH8; Q9BX17; Q9NYX3;
DT   07-JUN-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   12-OCT-2022, entry version 186.
DE   RecName: Full=Serine/threonine-protein kinase ICK;
DE            EC=2.7.11.1 {ECO:0000269|PubMed:10699974};
DE   AltName: Full=Ciliogenesis associated kinase 1 {ECO:0000305};
DE   AltName: Full=Intestinal cell kinase;
DE            Short=hICK;
DE   AltName: Full=Laryngeal cancer kinase 2;
DE            Short=LCK2;
DE   AltName: Full=MAK-related kinase;
DE            Short=MRK;
GN   Name=CILK1; Synonyms=ICK, KIAA0936;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000312|EMBL:AAF37278.1};
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, CATALYTIC ACTIVITY,
RP   COFACTOR, ACTIVITY REGULATION, TISSUE SPECIFICITY, MUTAGENESIS OF LYS-33;
RP   LYS-34; LYS-36; LYS-38; THR-157 AND TYR-159, AND PHOSPHORYLATION AT THR-157
RP   AND TYR-159.
RC   TISSUE=Colon {ECO:0000269|PubMed:10699974};
RX   PubMed=10699974;
RX   DOI=10.1002/(sici)1097-4652(200004)183:1<129::aid-jcp15>3.0.co;2-s;
RA   Togawa K., Yan Y.-X., Inomoto T., Slaugenhaupt S.A., Rustgi A.K.;
RT   "Intestinal cell kinase (ICK) localizes to the crypt region and requires a
RT   dual phosphorylation site found in map kinases.";
RL   J. Cell. Physiol. 183:129-139(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=12103360; DOI=10.1016/s1389-0344(02)00002-3;
RA   Yang T., Jiang Y., Chen J.;
RT   "The identification and subcellular localization of human MRK.";
RL   Biomol. Eng. 19:1-4(2002).
RN   [3] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain {ECO:0000312|EMBL:BAA76780.2};
RX   PubMed=10231032; DOI=10.1093/dnares/6.1.63;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIII. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 6:63-70(1999).
RN   [4] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain {ECO:0000312|EMBL:AAH35807.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   SUBCELLULAR LOCATION (ISOFORM 2).
RX   PubMed=15988018; DOI=10.1128/mcb.25.14.6047-6064.2005;
RA   Fu Z., Schroeder M.J., Shabanowitz J., Kaldis P., Togawa K., Rustgi A.K.,
RA   Hunt D.F., Sturgill T.W.;
RT   "Activation of a nuclear Cdc2-related kinase within a mitogen-activated
RT   protein kinase-like TDY motif by autophosphorylation and cyclin-dependent
RT   protein kinase-activating kinase.";
RL   Mol. Cell. Biol. 25:6047-6064(2005).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [10]
RP   FUNCTION, SUBCELLULAR LOCATION, AND CHARACTERIZATION OF VARIANT ECO
RP   GLN-272.
RX   PubMed=24797473; DOI=10.1002/embj.201488175;
RA   Chaya T., Omori Y., Kuwahara R., Furukawa T.;
RT   "ICK is essential for cell type-specific ciliogenesis and the regulation of
RT   ciliary transport.";
RL   EMBO J. 33:1227-1242(2014).
RN   [11]
RP   FUNCTION, AND CHARACTERIZATION OF VARIANT ECO GLN-272.
RX   PubMed=24853502; DOI=10.1073/pnas.1323161111;
RA   Moon H., Song J., Shin J.O., Lee H., Kim H.K., Eggenschwiller J.T., Bok J.,
RA   Ko H.W.;
RT   "Intestinal cell kinase, a protein associated with endocrine-cerebro-
RT   osteodysplasia syndrome, is a key regulator of cilia length and Hedgehog
RT   signaling.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:8541-8546(2014).
RN   [12]
RP   VARIANTS [LARGE SCALE ANALYSIS] TYR-115; ILE-320; LYS-471; GLN-476 AND
RP   THR-615.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [13]
RP   VARIANT ECO GLN-272, CHARACTERIZATION OF VARIANT ECO GLN-272, CATALYTIC
RP   ACTIVITY, AND SUBCELLULAR LOCATION.
RX   PubMed=19185282; DOI=10.1016/j.ajhg.2008.12.017;
RA   Lahiry P., Wang J., Robinson J.F., Turowec J.P., Litchfield D.W.,
RA   Lanktree M.B., Gloor G.B., Puffenberger E.G., Strauss K.A., Martens M.B.,
RA   Ramsay D.A., Rupar C.A., Siu V., Hegele R.A.;
RT   "A multiplex human syndrome implicates a key role for intestinal cell
RT   kinase in development of central nervous, skeletal, and endocrine
RT   systems.";
RL   Am. J. Hum. Genet. 84:134-147(2009).
RN   [14]
RP   INVOLVEMENT IN EJM10, VARIANTS EJM10 LEU-102; GLU-220; THR-305;
RP   369-PRO--LEU-373 DEL; THR-615 AND ARG-632 DEL, CHARACTERIZATION OF VARIANT
RP   ECO GLN-272, VARIANT ILE-320, AND CHARACTERIZATION OF VARIANTS EJM10
RP   GLU-220; THR-305; THR-615 AND ARG-632 DEL.
RX   PubMed=29539279; DOI=10.1056/nejmoa1700175;
RA   Bailey J.N., de Nijs L., Bai D., Suzuki T., Miyamoto H., Tanaka M.,
RA   Patterson C., Lin Y.C., Medina M.T., Alonso M.E., Serratosa J.M.,
RA   Duron R.M., Nguyen V.H., Wight J.E., Martinez-Juarez I.E., Ochoa A.,
RA   Jara-Prado A., Guilhoto L., Molina Y., Yacubian E.M., Lopez-Ruiz M.,
RA   Inoue Y., Kaneko S., Hirose S., Osawa M., Oguni H., Fujimoto S.,
RA   Grisar T.M., Stern J.M., Yamakawa K., Lakaye B., Delgado-Escueta A.V.;
RT   "Variant intestinal-cell kinase in juvenile myoclonic epilepsy.";
RL   N. Engl. J. Med. 378:1018-1028(2018).
CC   -!- FUNCTION: Required for ciliogenesis (PubMed:24797473). Phosphorylates
CC       KIF3A (By similarity). Involved in the control of ciliary length
CC       (PubMed:24853502). Regulates the ciliary localization of SHH pathway
CC       components as well as the localization of IFT components at ciliary
CC       tips (By similarity). May play a key role in the development of
CC       multiple organ systems and particularly in cardiac development (By
CC       similarity). Regulates intraflagellar transport (IFT) speed and
CC       negatively regulates cilium length in a cAMP and mTORC1 signaling-
CC       dependent manner and this regulation requires its kinase activity (By
CC       similarity). {ECO:0000250|UniProtKB:Q62726,
CC       ECO:0000250|UniProtKB:Q9JKV2, ECO:0000269|PubMed:24797473,
CC       ECO:0000269|PubMed:24853502}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000269|PubMed:10699974, ECO:0000269|PubMed:19185282};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000269|PubMed:10699974,
CC         ECO:0000269|PubMed:19185282};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:10699974};
CC   -!- INTERACTION:
CC       Q9UPZ9; P08238: HSP90AB1; NbExp=3; IntAct=EBI-6381479, EBI-352572;
CC       Q9UPZ9; Q9NRG4: SMYD2; NbExp=2; IntAct=EBI-6381479, EBI-1055671;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12103360,
CC       ECO:0000269|PubMed:19185282}. Cytoplasm, cytosol
CC       {ECO:0000250|UniProtKB:Q62726}. Cell projection, cilium
CC       {ECO:0000269|PubMed:24797473}. Cytoplasm, cytoskeleton, cilium basal
CC       body {ECO:0000250|UniProtKB:Q9JKV2}. Note=Also found at the ciliary tip
CC       (PubMed:24797473). Nuclear localization has been observed with a GFP-
CC       tagged construct in transfected HeLa cells (PubMed:12103360,
CC       PubMed:19185282). {ECO:0000269|PubMed:12103360,
CC       ECO:0000269|PubMed:19185282, ECO:0000269|PubMed:24797473}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Cytoplasm
CC       {ECO:0000269|PubMed:15988018}. Note=Predominant cytoplasmic
CC       localization has been observed with a N-terminally GFP-tagged
CC       construct. {ECO:0000269|PubMed:15988018}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1 {ECO:0000269|PubMed:10699974};
CC         IsoId=Q9UPZ9-1; Sequence=Displayed;
CC       Name=2 {ECO:0000305};
CC         IsoId=Q9UPZ9-2; Sequence=VSP_050752, VSP_050753;
CC   -!- TISSUE SPECIFICITY: Expressed in heart, brain, placenta, pancreas,
CC       thymus, prostate, testis, ovary, small intestine and colon, with
CC       highest levels in placenta and testis. Not detected in spleen. Also
CC       expressed in many cancer cell lines. {ECO:0000269|PubMed:10699974,
CC       ECO:0000269|PubMed:12103360}.
CC   -!- PTM: Autophosphorylated on serine and threonine residues.
CC       Phosphorylation at Thr-157 increases kinase activity.
CC       {ECO:0000269|PubMed:10699974}.
CC   -!- DISEASE: Endocrine-cerebroosteodysplasia (ECO) [MIM:612651]: Previously
CC       unidentified neonatal lethal recessive disorder with multiple anomalies
CC       involving the endocrine, cerebral, and skeletal systems.
CC       {ECO:0000269|PubMed:19185282, ECO:0000269|PubMed:24797473,
CC       ECO:0000269|PubMed:24853502, ECO:0000269|PubMed:29539279}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Juvenile myoclonic epilepsy 10 (EJM10) [MIM:617924]: A form of
CC       juvenile myoclonic epilepsy, a subtype of idiopathic generalized
CC       epilepsy generally characterized by afebrile seizures with onset in
CC       adolescence (rather than in childhood) and myoclonic jerks, which
CC       usually occur after awakening and are triggered by sleep deprivation
CC       and fatigue. EJM10 is an autosomal dominant seizure disorder with
CC       variable manifestations, even within families. Affected individuals
CC       have febrile, myoclonic, tonic-clonic, or absence seizures, although
CC       several seizure types can occur in the same individual. Some patients
CC       have onset of seizures in the first years of life.
CC       {ECO:0000269|PubMed:29539279}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC Ser/Thr
CC       protein kinase family. CDC2/CDKX subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA76780.2; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF225919; AAF37278.1; -; mRNA.
DR   EMBL; AF152469; AAG43364.1; -; mRNA.
DR   EMBL; AB023153; BAA76780.2; ALT_INIT; mRNA.
DR   EMBL; AL031178; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL162581; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471081; EAX04400.1; -; Genomic_DNA.
DR   EMBL; BC035807; AAH35807.1; -; mRNA.
DR   EMBL; BC136420; AAI36421.1; -; mRNA.
DR   EMBL; BC136421; AAI36422.1; -; mRNA.
DR   EMBL; BC152464; AAI52465.1; -; mRNA.
DR   CCDS; CCDS4949.1; -. [Q9UPZ9-1]
DR   RefSeq; NP_055735.1; NM_014920.3. [Q9UPZ9-1]
DR   RefSeq; NP_057597.2; NM_016513.4. [Q9UPZ9-1]
DR   RefSeq; XP_016865977.1; XM_017010488.1.
DR   RefSeq; XP_016865978.1; XM_017010489.1.
DR   RefSeq; XP_016865979.1; XM_017010490.1.
DR   RefSeq; XP_016865980.1; XM_017010491.1.
DR   RefSeq; XP_016865981.1; XM_017010492.1.
DR   AlphaFoldDB; Q9UPZ9; -.
DR   SMR; Q9UPZ9; -.
DR   BioGRID; 116527; 55.
DR   IntAct; Q9UPZ9; 33.
DR   MINT; Q9UPZ9; -.
DR   STRING; 9606.ENSP00000349458; -.
DR   BindingDB; Q9UPZ9; -.
DR   ChEMBL; CHEMBL1163126; -.
DR   DrugBank; DB12010; Fostamatinib.
DR   DrugCentral; Q9UPZ9; -.
DR   iPTMnet; Q9UPZ9; -.
DR   PhosphoSitePlus; Q9UPZ9; -.
DR   BioMuta; ICK; -.
DR   DMDM; 48428273; -.
DR   EPD; Q9UPZ9; -.
DR   jPOST; Q9UPZ9; -.
DR   MassIVE; Q9UPZ9; -.
DR   PaxDb; Q9UPZ9; -.
DR   PeptideAtlas; Q9UPZ9; -.
DR   PRIDE; Q9UPZ9; -.
DR   ProteomicsDB; 85480; -. [Q9UPZ9-1]
DR   ProteomicsDB; 85481; -. [Q9UPZ9-2]
DR   Antibodypedia; 605; 296 antibodies from 23 providers.
DR   DNASU; 22858; -.
DR   Ensembl; ENST00000356971.3; ENSP00000349458.3; ENSG00000112144.16. [Q9UPZ9-1]
DR   Ensembl; ENST00000676107.1; ENSP00000501692.1; ENSG00000112144.16. [Q9UPZ9-1]
DR   GeneID; 22858; -.
DR   KEGG; hsa:22858; -.
DR   MANE-Select; ENST00000676107.1; ENSP00000501692.1; NM_014920.5; NP_055735.1.
DR   UCSC; uc003pbh.3; human. [Q9UPZ9-1]
DR   CTD; 22858; -.
DR   DisGeNET; 22858; -.
DR   GeneCards; CILK1; -.
DR   HGNC; HGNC:21219; CILK1.
DR   HPA; ENSG00000112144; Low tissue specificity.
DR   MalaCards; CILK1; -.
DR   MIM; 612325; gene.
DR   MIM; 612651; phenotype.
DR   MIM; 617924; phenotype.
DR   neXtProt; NX_Q9UPZ9; -.
DR   OpenTargets; ENSG00000112144; -.
DR   Orphanet; 199332; Endocrine-cerebro-osteodysplasia syndrome.
DR   Orphanet; 307; Juvenile myoclonic epilepsy.
DR   VEuPathDB; HostDB:ENSG00000112144; -.
DR   eggNOG; KOG0661; Eukaryota.
DR   GeneTree; ENSGT00940000158807; -.
DR   HOGENOM; CLU_000288_181_25_1; -.
DR   InParanoid; Q9UPZ9; -.
DR   OrthoDB; 76933at2759; -.
DR   PhylomeDB; Q9UPZ9; -.
DR   TreeFam; TF328769; -.
DR   PathwayCommons; Q9UPZ9; -.
DR   SignaLink; Q9UPZ9; -.
DR   SIGNOR; Q9UPZ9; -.
DR   BioGRID-ORCS; 22858; 12 hits in 1109 CRISPR screens.
DR   ChiTaRS; ICK; human.
DR   GeneWiki; ICK_(gene); -.
DR   GenomeRNAi; 22858; -.
DR   Pharos; Q9UPZ9; Tchem.
DR   PRO; PR:Q9UPZ9; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; Q9UPZ9; protein.
DR   Bgee; ENSG00000112144; Expressed in adrenal tissue and 186 other tissues.
DR   ExpressionAtlas; Q9UPZ9; baseline and differential.
DR   Genevisible; Q9UPZ9; HS.
DR   GO; GO:0036064; C:ciliary basal body; ISS:UniProtKB.
DR   GO; GO:0097546; C:ciliary base; ISS:UniProtKB.
DR   GO; GO:0097542; C:ciliary tip; IMP:UniProtKB.
DR   GO; GO:0005929; C:cilium; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IEA:UniProtKB-SubCell.
DR   GO; GO:0001650; C:fibrillar center; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0004672; F:protein kinase activity; IDA:UniProtKB.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0060271; P:cilium assembly; IMP:UniProtKB.
DR   GO; GO:0035556; P:intracellular signal transduction; IDA:UniProtKB.
DR   GO; GO:0035720; P:intraciliary anterograde transport; ISS:UniProtKB.
DR   GO; GO:0035721; P:intraciliary retrograde transport; ISS:UniProtKB.
DR   GO; GO:0042073; P:intraciliary transport; ISS:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; TAS:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cell projection;
KW   Cilium biogenesis/degradation; Cytoplasm; Cytoskeleton;
KW   Developmental protein; Disease variant; Epilepsy; Kinase; Magnesium;
KW   Metal-binding; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase.
FT   CHAIN           1..632
FT                   /note="Serine/threonine-protein kinase ICK"
FT                   /id="PRO_0000086007"
FT   DOMAIN          4..284
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000305"
FT   REGION          290..344
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          457..481
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          582..632
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        314..328
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        330..344
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        462..480
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        125
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         10..18
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P06493,
FT                   ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         33
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000269|PubMed:10699974"
FT   MOD_RES         157
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000269|PubMed:10699974"
FT   MOD_RES         159
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000269|PubMed:10699974"
FT   MOD_RES         161
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JKV2"
FT   VAR_SEQ         278..292
FT                   /note="ALRYPYFQVGHPLGS -> VFFHFLVITFISNSE (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_050752"
FT   VAR_SEQ         293..632
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_050753"
FT   VARIANT         98
FT                   /note="P -> L (in dbSNP:rs1493105)"
FT                   /id="VAR_053931"
FT   VARIANT         102
FT                   /note="I -> L (in EJM10; unknown pathological significance;
FT                   dbSNP:rs748539319)"
FT                   /evidence="ECO:0000269|PubMed:29539279"
FT                   /id="VAR_080554"
FT   VARIANT         115
FT                   /note="F -> Y (in a renal clear cell carcinoma sample;
FT                   somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042001"
FT   VARIANT         220
FT                   /note="K -> E (in EJM10; impairs mitosis, cell-cycle exit
FT                   and radial neuroblast migration, while promoting apoptosis,
FT                   when tested in a heterologous system)"
FT                   /evidence="ECO:0000269|PubMed:29539279"
FT                   /id="VAR_080555"
FT   VARIANT         272
FT                   /note="R -> Q (in ECO; significantly impairs kinase
FT                   activity; decreased localization at the ciliary tips;
FT                   impaired ciliogenesis; results in abnormally elongated
FT                   cilia; impairs mitosis, cell-cycle exit and radial
FT                   neuroblast migration, while promoting apoptosis, when
FT                   tested in a heterologous system; loss of nuclear
FT                   localization; dbSNP:rs118203918)"
FT                   /evidence="ECO:0000269|PubMed:19185282,
FT                   ECO:0000269|PubMed:24797473, ECO:0000269|PubMed:24853502,
FT                   ECO:0000269|PubMed:29539279"
FT                   /id="VAR_057994"
FT   VARIANT         305
FT                   /note="K -> T (in EJM10; impairs mitosis, cell-cycle exit
FT                   and radial neuroblast migration, while promoting apoptosis,
FT                   when tested in a heterologous system; dbSNP:rs765078446)"
FT                   /evidence="ECO:0000269|PubMed:29539279"
FT                   /id="VAR_080556"
FT   VARIANT         320
FT                   /note="V -> I (in dbSNP:rs33936662)"
FT                   /evidence="ECO:0000269|PubMed:17344846,
FT                   ECO:0000269|PubMed:29539279"
FT                   /id="VAR_042002"
FT   VARIANT         369..373
FT                   /note="Missing (in EJM10; unknown pathological
FT                   significance; dbSNP:rs201964851)"
FT                   /evidence="ECO:0000269|PubMed:29539279"
FT                   /id="VAR_080557"
FT   VARIANT         471
FT                   /note="T -> K (in dbSNP:rs56164633)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042003"
FT   VARIANT         476
FT                   /note="R -> Q (in dbSNP:rs55895113)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042004"
FT   VARIANT         615
FT                   /note="A -> T (in EJM10; unknown pathological significance;
FT                   impairs mitosis, cell-cycle exit and radial neuroblast
FT                   migration, while promoting apoptosis, when tested in a
FT                   heterologous system; dbSNP:rs55932059)"
FT                   /evidence="ECO:0000269|PubMed:17344846,
FT                   ECO:0000269|PubMed:29539279"
FT                   /id="VAR_042005"
FT   VARIANT         632
FT                   /note="Missing (in EJM10; impairs mitosis, cell-cycle exit
FT                   and radial neuroblast migration, while promoting apoptosis,
FT                   when tested in a heterologous system)"
FT                   /evidence="ECO:0000269|PubMed:29539279"
FT                   /id="VAR_080558"
FT   MUTAGEN         33
FT                   /note="K->R: Loss of activity and autophosphorylation; when
FT                   associated with R-34; R-36 and R-38."
FT                   /evidence="ECO:0000269|PubMed:10699974"
FT   MUTAGEN         34
FT                   /note="K->R: Loss of activity and autophosphorylation; when
FT                   associated with R-33; R-36 and R-38."
FT                   /evidence="ECO:0000269|PubMed:10699974"
FT   MUTAGEN         36
FT                   /note="K->R: Loss of activity and autophosphorylation; when
FT                   associated with R-33; R-34 and R-38."
FT                   /evidence="ECO:0000269|PubMed:10699974"
FT   MUTAGEN         38
FT                   /note="K->R: Loss of activity and autophosphorylation; when
FT                   associated with R-33; R-34 and R-36."
FT                   /evidence="ECO:0000269|PubMed:10699974"
FT   MUTAGEN         157
FT                   /note="T->A: Reduction of activity and loss of
FT                   autophosphorylation. Loss of activity and
FT                   autophosphorylation; when associated with F-159."
FT                   /evidence="ECO:0000269|PubMed:10699974"
FT   MUTAGEN         159
FT                   /note="Y->F: Reduction of activity and loss of
FT                   autophosphorylation. Loss of activity and
FT                   autophosphorylation; when associated with A-157."
FT                   /evidence="ECO:0000269|PubMed:10699974"
FT   CONFLICT        48
FT                   /note="L -> Q (in Ref. 1; AAF37278)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        119
FT                   /note="H -> L (in Ref. 1; AAF37278)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        310
FT                   /note="K -> R (in Ref. 1; AAF37278)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        598..599
FT                   /note="FH -> LD (in Ref. 1; AAF37278)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        629
FT                   /note="A -> P (in Ref. 1; AAF37278)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   632 AA;  71427 MW;  F4C22C6CCD5878D2 CRC64;
     MNRYTTIRQL GDGTYGSVLL GRSIESGELI AIKKMKRKFY SWEECMNLRE VKSLKKLNHA
     NVVKLKEVIR ENDHLYFIFE YMKENLYQLI KERNKLFPES AIRNIMYQIL QGLAFIHKHG
     FFHRDLKPEN LLCMGPELVK IADFGLAREI RSKPPYTDYV STRWYRAPEV LLRSTNYSSP
     IDVWAVGCIM AEVYTLRPLF PGASEIDTIF KICQVLGTPK KTDWPEGYQL SSAMNFRWPQ
     CVPNNLKTLI PNASSEAVQL LRDMLQWDPK KRPTASQALR YPYFQVGHPL GSTTQNLQDS
     EKPQKGILEK AGPPPYIKPV PPAQPPAKPH TRISSRQHQA SQPPLHLTYP YKAEVSRTDH
     PSHLQEDKPS PLLFPSLHNK HPQSKITAGL EHKNGEIKPK SRRRWGLISR STKDSDDWAD
     LDDLDFSPSL SRIDLKNKKR QSDDTLCRFE SVLDLKPSEP VGTGNSAPTQ TSYQRRDTPT
     LRSAAKQHYL KHSRYLPGIS IRNGILSNPG KEFIPPNPWS SSGLSGKSSG TMSVISKVNS
     VGSSSTSSSG LTGNYVPSFL KKEIGSAMQR VHLAPIPDPS PGYSSLKAMR PHPGRPFFHT
     QPRSTPGLIP RPPAAQPVHG RTDWASKYAS RR
//
